Long‐term evolution of LI‐RADS observations in HCV‐related cirrhosis treated with direct‐acting antivirals

• Published in: Liver international Vol. 41; no. 9; pp. 2179 - 2188
• Main Authors: Cannella, Roberto, Vernuccio, Federica, Celsa, Ciro, Cabibbo, Giuseppe, Calvaruso, Vincenza, Greco, Silvia, Battaglia, Salvatore, Choudhury, Kingshuk Roy, Tang, An, Midiri, Massimo, Di Marco, Vito, Cammà, Calogero, Brancatelli, Giuseppe
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01.09.2021
• Subjects: Antiviral agents; Cirrhosis; direct‐Acting Antivirals; Evaluation; Evolution; hepatitis C; Hepatocellular carcinoma; Liver cirrhosis; LI‐RADS; Magnetic resonance imaging; Multivariate analysis; Rank tests; Statistical models; hepatocellular Carcinoma; LI-RADS; hepatitis C; cirrhosis; direct-Acting Antivirals

Background & Aims The risk of progression of indeterminate observations to hepatocellular carcinoma (HCC) after direct‐acting antivirals (DAA) is still undetermined. To assess whether DAA therapy changes the risk of progression of observations with low (LR‐2), intermediate (LR‐3) and high (LR‐4)...